# Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

> **NCT02016183** · — · COMPLETED · sponsor: **Takeda** · enrollment: 3222 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Candesartan cilexetil / hydrochlorothiazide

## Key facts

- **NCT ID:** NCT02016183
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-01
- **Primary completion:** 2012-09-30
- **Final completion:** 2012-09-30
- **Target enrollment:** 3222 (ACTUAL)
- **Last updated:** 2018-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016183, "Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02016183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*